Table 2.
Neonatal characteristics and neurologic outcome of subjects with perinatal brain injury
| HIE | Stroke | ICH | |
|---|---|---|---|
|
|
|
|
|
| Neonatal characteristics | (n = 57) | (n = 18) | (n = 9) |
| Male, n (%) | 30 (53) | 9 (50) | 6 (67) |
| Gestational age, w, median (IQR) | 39 (38, 40) | 38 (38, 40) | 39 (39, 40) |
| Birth weight, kg, median (IQR) | 3.2 (3.0, 3.6) | 3.3 (3.1, 3.4) | 3.5 (2.9, 3.6) |
| Race, n (%) | |||
| White | 38 (83) | 12 (86) | 8 (100) |
| Black/African American | 5 (11) | 2 (14) | 0 |
| Other | 3 (7) | 0 | 0 |
| Unreported | 11 | 4 | 1 |
| Ethnicity, Hispanic or Latino, n (%) | 11 (19) | 3 (17) | 0 |
| Received therapeutic hypothermia, n (%) | 49 (86) | 0 | 0 |
| Clinical or EEG-confirmed neonatal seizures, n (%) | 33 (58) | 18 (100) | 8 (89) |
| Neonatal seizure burden, min/hr, median (IQR) | 0.0 (0.0, 3.1) | 1.5 (0.8, 3.6) | 3.4 (0.1, 5.5) |
| Neonatal status epilepticus, n (%) | 9 (16) | 4 (22) | 2 (22) |
| EEG duration, hr, median (IQR) | 74.5 (52.1, 92.0) | 57.7 (48.1, 80.5) | 83.4 (71.3, 105.5) |
| Neurodevelopmental testing | (n = 46) | (n = 16) | (n = 7) |
| Age at testing, m, median (IQR) | 20 (18, 22) | 18 (18, 20) | 19 (18, 22) |
| Bayley-III Composite Scores, mean ± SD | |||
| Cognitive | 93.2 ± 17.9 | 97.7 ± 8.6 | 96.4 ± 9.9 |
| Language | 90.4 ± 18.5 | 92.5 ± 12.3 | 92.1 ± 10.1 |
| Motor | 92.5 ± 18.6 | 93.3 ± 12.3 | 97.4 ± 7.8 |
| Vineland-II Composite Scores, mean ± SD | |||
| Adaptive Behavior | 90.0 ± 17.6 | 93.7 ± 10.1 | 93.0 ± 4.5 |
| Communication | 88.7 ± 17.7 | 93.3 ± 12.3 | 91.3 ± 6.5 |
| Motor Skills | 92.6 ± 24.1 | 95.3 ± 11.9 | 97.2 ± 7.3 |
| Post-neonatal outcome, n/total (%) | |||
| Post-neonatal seizure(s) | 8/56 (14) | 4/18 (22) | 1/9 (11) |
| Confirmed SNHL | 3/57 (5) | 0/18 (0) | 0/9 (0) |
| Suspected or confirmed CVI | 3/50 (6) | 0/18 (0) | 0/8 (0) |
| Abnormal neurologic outcome | 13/42 (31) | 4/17 (24) | 1/8 (13) |
Abbreviations: HIE, hypoxic-ischemic encephalopathy; ICH, intracranial hemorrhage; IQR, interquartile range; SD, standard deviation; SNHL, sensorineural hearing loss; CVI, cerebral visual impairment